Dow Up 2.00% Nasdaq Up 1.66%

CytRx Corporation (CYTR)

-NasdaqCM
2.50 Up 0.37(17.37%) Feb 12, 4:00PM EST
Prev Close:2.13
Open:2.15
Bid:1.96 x 1000
Ask:2.67 x 100
1y Target Est:7.40
Beta:2.94996
Earnings Date:Mar 8 - Mar 14 (Est.)
Day's Range:2.15 - 2.57
52wk Range:1.55 - 5.42
Volume:1,271,065
Avg Vol (3m):467,595
Market Cap:166.20M
P/E (ttm):N/A
EPS (ttm):-0.86
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTRUp 17.37%166.20M
LLYDown 0.21%75.47B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,416.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.81
Quarterly EPS Est (Dec-15) :-0.20
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback